TrialGut2018

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.

Khurum Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.